Inari Medical Top Insiders
NARIDelisted Stock | USD 79.97 0.00 0.00% |
Inari Medical employs about 1.3 K people. The company is managed by 21 executives with a total tenure of roughly 3034 years, averaging almost 144.0 years of service per executive, having 61.9 employees per reported executive. Assessment of Inari Medical's management performance can provide insight into the firm performance.
Inari |
Inari Medical Management Team Effectiveness
The company has return on total asset (ROA) of (0.0321) % which means that it has lost $0.0321 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1772) %, meaning that it created substantial loss on money invested by shareholders. Inari Medical's management efficiency ratios could be used to measure how well Inari Medical manages its routine affairs as well as how well it operates its assets and liabilities.Inari Medical Workforce Comparison
Inari Medical is regarded third in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 6,840. Inari Medical retains roughly 1,300 in number of employees claiming about 19% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.04) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.04. Inari Medical Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inari Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inari Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Inari Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Szyman Catherine M. over a week ago Disposition of 22429 shares by Szyman Catherine M. of Inari Medical subject to Rule 16b-3 | ||
Tu Thomas over two weeks ago Disposition of 516 shares by Tu Thomas of Inari Medical at 51.05 subject to Rule 16b-3 | ||
Tu Thomas over three weeks ago Disposition of 478767 shares by Tu Thomas of Inari Medical subject to Rule 16b-3 | ||
Tu Thomas over a month ago Disposition of 8420 shares by Tu Thomas of Inari Medical at 6.4546 subject to Rule 16b-3 | ||
Karen Silva over a month ago Acquisition by Karen Silva of 5504 shares of Inari Medical subject to Rule 16b-3 | ||
Kevin Strange over a month ago Disposition of 276 shares by Kevin Strange of Inari Medical at 51.05 subject to Rule 16b-3 | ||
William Hoffman over two months ago Disposition of 1533 shares by William Hoffman of Inari Medical at 51.05 subject to Rule 16b-3 | ||
Andrew Hykes over two months ago Disposition of 600 shares by Andrew Hykes of Inari Medical at 55.65 subject to Rule 16b-3 |
Inari Medical Notable Stakeholders
An Inari Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Inari Medical often face trade-offs trying to please all of them. Inari Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Inari Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Angela JD | General Secretary | Profile | |
Tara Dunn | Senior Development | Profile | |
John Borrell | Senior Sales | Profile | |
Kevin Strange | Accounting, Finance | Profile | |
Janet Byk | VP Accounting | Profile | |
John CFA | Vice Relations | Profile | |
Karen Silva | Vice Accounting | Profile | |
Tim Benner | Chief Officer | Profile | |
Eric Khairy | Senior Marketing | Profile | |
Neil Bhalodkar | Vice Relations | Profile | |
Angela Ahmad | General Secretary | Profile | |
Dena Truelove | VP HR | Profile | |
Paul Koehn | Senior Operations | Profile | |
William Hoffman | Pres CEO | Profile | |
Brian Strauss | Senior Engineering | Profile | |
Hussain Rangwala | Chief Officer | Profile | |
Andrew Hykes | Chief Officer | Profile | |
Shannon Trevino | General Secretary | Profile | |
Mitchell Hill | Chief Officer | Profile | |
Thomas MD | Chief Officer | Profile | |
MPH MD | Chief LimFlow | Profile |
About Inari Medical Management Performance
The success or failure of an entity such as Inari Medical often depends on how effective the management is. Inari Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Inari management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Inari management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. Inari Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 800 people.
Inari Medical Workforce Analysis
Traditionally, organizations such as Inari Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Inari Medical within its industry.Inari Medical Manpower Efficiency
Return on Inari Medical Manpower
Revenue Per Employee | 379.7K | |
Revenue Per Executive | 23.5M | |
Net Loss Per Employee | 1.3K | |
Net Loss Per Executive | 77.9K | |
Working Capital Per Employee | 122.5K | |
Working Capital Per Executive | 7.6M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Inari Stock
If you are still planning to invest in Inari Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Inari Medical's history and understand the potential risks before investing.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |